Yellow fever is very much still around. The World Health Organization estimates that 67,000 to 173,000 severe infections and 31,000 to 82,000 deaths occur every year, with the vast majority in Africa and a smaller share in South America. While the disease was eliminated from North America and Europe over a century ago, it remains a serious and sometimes fatal threat in tropical regions of two continents.
Where Yellow Fever Exists Today
Yellow fever circulates actively in sub-Saharan Africa and tropical South America. Africa bears most of the global burden. The virus has never been present in Asia, though the mosquitoes capable of spreading it live there, which keeps public health officials vigilant.
The last major outbreak in the United States happened in 1905 in New Orleans. Mosquito control programs and widespread vaccination eliminated the disease from temperate regions. But in tropical areas, the virus persists in monkey populations deep in forest canopies, making true eradication essentially impossible. Even if every human case were prevented, the virus would continue circulating among primates and forest mosquitoes, ready to spill back into human populations.
How the Virus Spreads
Yellow fever spreads through mosquito bites, not from person to person through casual contact. The virus moves through three distinct cycles, each with different implications for who’s at risk.
- Jungle cycle: Mosquitoes in the forest canopy pass the virus between monkeys. Humans get infected when they enter the forest for work or travel. This is the most common route for sporadic cases.
- Intermediate cycle: Found in African savannah regions, where people live or work near the edges of forests. Mosquitoes can transmit the virus from monkeys to humans or between humans.
- Urban cycle: The most dangerous scenario. A person infected in the jungle travels to a city, where urban mosquitoes (primarily Aedes aegypti, the same species that spreads dengue and Zika) pick up the virus and spread it rapidly through dense populations.
Rainy seasons create ideal breeding conditions for all these mosquito species, which is why outbreaks tend to follow seasonal patterns in tropical regions.
Why Outbreaks Keep Happening
Several forces are pushing yellow fever risk higher rather than lower. Urban development is creeping toward forested zones where the virus circulates in monkeys, shrinking the buffer between jungle and city. Deforestation and ecological fragmentation bring infected forest mosquitoes into closer contact with people. Illegal logging and mining operations send unvaccinated workers deep into high-risk areas with no access to healthcare.
Climate variability plays a role too. Shifting rainfall patterns can expand mosquito breeding grounds into areas that were previously too dry. Cross-border migration and political instability in parts of Africa and South America disrupt vaccination campaigns and disease surveillance. Remote rainforest communities face especially tough challenges: rugged terrain and limited health infrastructure make routine immunization difficult to deliver. The result is pockets of unprotected people living in exactly the places where the virus is most active.
What Yellow Fever Does to the Body
Many people infected with yellow fever have mild symptoms or none at all. Those who do get sick typically experience a sudden high fever (up to 104°F), chills, severe headache, muscle pain especially in the back, nausea, and vomiting. This acute phase lasts about three days, and most people recover without complications.
About 15% of infected people aren’t as fortunate. Within 48 hours of feeling better, the illness returns in a far more dangerous form. This toxic phase brings back the fever along with jaundice (the yellowing of skin and eyes that gives the disease its name), kidney problems, and cardiovascular instability. Bleeding complications can develop. The toxic phase is where yellow fever becomes life-threatening, and a significant portion of people who reach this stage do not survive.
One Vaccine, Lifelong Protection
The yellow fever vaccine is one of the most effective vaccines ever developed. A single dose provides lifelong protection for most people. No booster is needed under normal circumstances, though travelers heading to areas with active outbreaks may consider a booster if their last dose was more than 10 years ago.
The vaccine is so central to international public health that many countries require proof of vaccination before allowing entry. These requirements apply not only to travelers arriving from countries where yellow fever is endemic but sometimes to anyone who has even had a brief layover in a risk area. Your vaccination certificate becomes valid 10 days after the shot, so timing matters if you’re planning a trip. Travelers who can’t show a valid certificate may be denied entry, placed in quarantine, or vaccinated on the spot at the border. Medical exemptions exist but are granted at the discretion of the destination country, and not all countries accept them.
The Gap Between Vaccine and Coverage
The paradox of yellow fever in 2025 is that a safe, effective, one-dose vaccine exists, yet tens of thousands of people still die from the disease each year. The gap is almost entirely about access and logistics. Vaccine uptake remains insufficient in many high-risk groups, particularly in remote communities where supply chains are unreliable and healthcare workers are scarce. Fragmented surveillance systems mean outbreaks can gain momentum before they’re even detected.
International efforts, including a WHO-backed initiative to vaccinate hundreds of millions of people across Africa, have made progress but haven’t closed the gap. As long as the virus thrives in monkey populations across two continents and unvaccinated people live within mosquito range, yellow fever will remain a present-day reality rather than a historical footnote.